Ep. Chen et al., NITRIC-OXIDE IMPROVES PULMONARY VASCULAR IMPEDANCE, TRANSPULMONARY EFFICIENCY, AND LEFT-VENTRICULAR FILLING IN CHRONIC PULMONARY-HYPERTENSION, Journal of thoracic and cardiovascular surgery, 113(5), 1997, pp. 849-857
Objective: Chronic pulmonary hypertension is difficult to treat and de
spite the introduction of several therapeutic options, no single thera
py is universally recommended, Nitric oxide has had some role clinical
ly in improving pulmonary hemodynamics in this setting; however, basic
investigation has not been performed in an appropriate large animal m
odel of stable pulmonary hypertension, This study was designed to exam
ine the effects of inhaled nitric oxide on pulmonary hemodynamics in t
he setting of a canine model of monocrotaline pyrrole-induced chronic
pulmonary hypertension and used Fourier analysis for assessment of pul
monary vascular impedance, Methods: Sixteen mongrel dogs (22 to 25 kg)
were used, Animals underwent percutaneous pulmonary artery catheteriz
ation to measure right-sided hemodynamics before and 6 weeks after a r
ight atrial injection of either monocrotaline pyrrole (n = 8) or place
bo (n = 8), Six weeks after the injection all hearts were instrumented
with an ultrasonic flow probe, sonomicrometric dimension transducers,
and micromanometers, Data were collected at baseline and after nitric
oxide administration, Harmonic derivation of functional data was achi
eved with Fourier analysis, Results: Six weeks after the injection, si
gnificant increases in pulmonary artery pressure and pulmonary vascula
r resistance were observed in the monocrotaline pyrrole group, Nitric
oxide led to significant decreases in pulmonary vascular impedance, Si
gnificant improvements in pulmonary blood how, transpulmonary efficien
cy, and left ventricular filling were also observed, Conclusions: This
investigation demonstrates the well-known clinical effects of nitric
oxide in improving pulmonary hypertension, which were also associated
with an increase in pulmonary blood flow, transpulmonary efficiency, a
nd left ventricular filling in the setting of monocrotaline pyrrole-in
duced pulmonary hypertension.